These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10862559)

  • 1. Endocrine disruptors: overview and a pathologist's perspective.
    Kennedy S
    Toxicol Pathol; 2000; 28(3):418-9. PubMed ID: 10862559
    [No Abstract]   [Full Text] [Related]  

  • 2. An introduction to endocrine modulators.
    Iatropoulos MJ
    Toxicol Pathol; 2000; 28(3):415-7. PubMed ID: 10862558
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a Tier I screening battery for detecting endocrine-active compounds (EACs).
    Cook JC; Kaplan MA; Davis LG; O'Connor JC
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):60-8. PubMed ID: 9339481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine modulators: risk characterization and assessment.
    Fenner-Crisp PA
    Toxicol Pathol; 2000; 28(3):438-40. PubMed ID: 10862562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endocrine disruptors on developmental and reproductive functions.
    Brevini TA; Zanetto SB; Cillo F
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):1-10. PubMed ID: 15777200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of in vitro and in vivo methods for assessing endocrine disrupting chemicals.
    Ashby J
    Toxicol Pathol; 2000; 28(3):432-7. PubMed ID: 10862561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition, classification and mechanism of action of endocrine disrupting chemicals.
    Wuttke W; Jarry H; Seidlova-Wuttke D
    Hormones (Athens); 2010; 9(1):9-15. PubMed ID: 20363717
    [No Abstract]   [Full Text] [Related]  

  • 8. Introduction to "screening for endocrine activity-experiences with the US EPA's endocrine disruptor screening program and future considerations".
    Marty S
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):1-2. PubMed ID: 24510782
    [No Abstract]   [Full Text] [Related]  

  • 9. An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs).
    O'Connor JC; Cook JC; Slone TW; Makovec GT; Frame SR; Davis LG
    Toxicol Sci; 1998 Nov; 46(1):45-60. PubMed ID: 9928668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated 28-day oral toxicity study of ketoconazole in rats based on the draft protocol for the "Enhanced OECD Test Guideline No. 407" to detect endocrine effects.
    Shin JH; Moon HJ; Kang IH; Kim TS; Kim IY; Park IS; Kim HS; Jeung EB; Han SY
    Arch Toxicol; 2006 Dec; 80(12):797-803. PubMed ID: 16710696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine disrupting chemicals: harmful substances and how to test them.
    Olea-Serrano N; Fernández-Cabrera MF; Pulgar-Encinas R; Olea-Serrano F
    Cad Saude Publica; 2002; 18(2):489-94. PubMed ID: 11923890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mercury on the endocrine system.
    Minoia C; Ronchi A; Pigatto P; Guzzi G
    Crit Rev Toxicol; 2009; 39(6):538; author reply 539. PubMed ID: 19545200
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of endocrine disruptors on ecology--reports from the Gordon Reserch Conference of Environmental Endrocrine Disruptors].
    Iguchi T; Watanabe H; Arisono K
    Nihon Rinsho; 2000 Dec; 58(12):2401-8. PubMed ID: 11187728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute iron overload leads to hypothalamic-pituitary-gonadal axis abnormalities in female rats.
    Rossi EM; Marques VB; Nunes Dde O; Carneiro MT; Podratz PL; Merlo E; dos Santos L; Graceli JB
    Toxicol Lett; 2016 Jan; 240(1):196-213. PubMed ID: 26536400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine disruptors: a new scientific role for clinical pharmacologists? Impact on human health, wildlife, and the environment.
    Lathers CM
    J Clin Pharmacol; 2002 Jan; 42(1):7-23. PubMed ID: 11808826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen: 28-day oral toxicity study in the rat based on the Enhanced OECD Test Guideline 407 to detect endocrine effects.
    Kennel P; Pallen C; Barale-Thomas E; Espuña G; Bars R
    Arch Toxicol; 2003 Sep; 77(9):487-99. PubMed ID: 12802581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Getting the problem of endocrine disruption into focus: the need for a pause for thought.
    Ashby J
    APMIS; 2000 Dec; 108(12):805-13. PubMed ID: 11252813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary: setting aside tradition when dealing with endocrine disruptors.
    Colborn T
    ILAR J; 2004; 45(4):394-400. PubMed ID: 15454678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models and studies of in utero endocrine disruptor effects.
    Vandenbergh JG
    ILAR J; 2004; 45(4):438-42. PubMed ID: 15454682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine disruptors and obesity: obesogens].
    García-Mayor RV; Larrañaga Vidal A; Docet Caamaño MF; Lafuente Giménez A
    Endocrinol Nutr; 2012 Apr; 59(4):261-7. PubMed ID: 22300604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.